Term ends no later than Mar 8, 2027 · Medium confidence
20-year base term ended Oct 26, 2026
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Oct 26, 2006
Mar 8, 2027
Nov 2, 2010
This patent's term runs 133 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 26, 2006, when application 11/588,638, the earliest non-provisional in its chain, was filed (this one was filed Apr 26, 2007) | Oct 26, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +133 days, USPTO patent term adjustment record | Mar 8, 2027 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Mar 8, 2027 | Medium confidence |
This family
| US 7,528,143 | In force no later than Nov 2031 | no later than Nov 2031 |
| US 7,825,246 | this patent no later than Mar 2027 | no later than Mar 2027 |
| US 8,133,900 | In force Sep 2027 | Sep 2027 |
| US 8,138,199 | In force Jun 2028 | Jun 2028 |
| US 8,604,042 | Term ended Oct 2026 | Oct 2026 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 24, 2007 Reel 19600, frame 122 | Noronha, Glenn; Mak, Chi Ching; Cao, Jianguo; Renick, Joel; McPherson, Andrew; Zeng, Binqi; Pathak, Ved P.; Lohse, Daniel L.; Hood, John D.; Soll, Richard M. | Targegen, Inc. | Assignment of Assignor's Interest |
| Oct 18, 2010 Reel 25154, frame 893 | Noronha, Glenn; Mak, Chi Ching; Cao, Jianguo; Renick, Joel; McPherson, Andrew; Zeng, Binqi; Pathak, Ved P.; Lohse, Daniel L.; Hood, John D.; Soll, Richard M. | Targegen, Inc. | Assignment of Assignor's Interest |
| Jun 25, 2012 Reel 28440, frame 123 | Noronha, Glenn; Mak, Chi Ching; Cao, Jianguo; Renick, Joel; McPherson, Andrew; Zeng, Binqi; Pathak, Ved P.; Lohse, Daniel L.; Hood, John D.; Soll, Richard M. | Targegen, Inc. | Corrective Assignment to Correct the State of Incorporation from a California Corporation to a Delaware Corporation for the Assignee Previously Recorded on Reel 025154 Frame 0893. Assignor(S) Hereby Confirms the State of Incorporation for Targegen, Inc. to Be a Delaware Corporation. |
| May 25, 2017 Reel 42586, frame 643 | Impact Therapeutics, Inc. | Impact Biomedicines, Inc. | Change of Name |
| May 25, 2017 Reel 42512, frame 179 | Targegen, Inc. | Impact Therapeutics, Inc. | Assignment of Assignor's Interest |
| Nov 30, 2017 Reel 44572, frame 660 | Impact Biomedicines, Inc. | Lind S.A., LLC, as Collateral Agent | Security Interest |
| Feb 12, 2018 Reel 44904, frame 628 | Lind S.A. LLC, as Collateral Agent | Impact Biomedicines, Inc. | Release of Security Interest |
| Aug 21, 2019 Reel 50297, frame 562 | Targegen, Inc. | Impact Biomedicines, Inc. | Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 042512 Frame: 0179. Assignor(S) Hereby Confirms the Assignment . |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Mar 8, 2027. We will not guess the cap.